Slideshows Images Quizzes

Carafate Suspension

Last reviewed on RxList: 9/26/2016
Carafate Suspension Side Effects Center

Last reviewed on RxList 9/21/2016

Carafate (sucralfate) Suspension is an anti-ulcer medication used to treat an active duodenal ulcer. Carafate can heal an active ulcer, but it will not prevent future ulcers from occurring. Carafate suspension is available in generic form. Common side effects of Carafate suspension include:

  • constipation,
  • diarrhea,
  • dry mouth,
  • upset stomach,
  • gas,
  • nausea,
  • vomiting,
  • stomach pain,
  • itching or skin rash,
  • sleep problems (insomnia),
  • dizziness,
  • drowsiness,
  • spinning sensation,
  • headache, or
  • back pain.

Tell your doctor if you experience unlikely but serious side effects of Carafate Suspension including:

  • unusual/persistent feeling of fullness in the stomach, or
  • nausea/vomiting/stomach pain especially after meals.

The recommended adult oral dosage for duodenal ulcer is 1 g (10 mL/2 teaspoonfuls) four times per day. Carafate should be administered on an empty stomach. Carafate may interact with cimetidine, digoxin, levothyroxine, phenytoin, quinidine, ranitidine, tetracycline, theophylline, blood thinners, or antibiotics. Tell your doctor all medications you use. During pregnancy, Carafate should be used only when prescribed. It is not known if this medication passes into breast milk. Consult your doctor before breastfeeding.

Our Carafate (sucralfate) Suspension Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Carafate Suspension Consumer Information

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Less serious side effects may include:

  • nausea, vomiting, upset stomach;
  • stomach pain;
  • constipation, diarrhea;
  • mild itching or skin rash;
  • sleep problems (insomnia);
  • dizziness, drowsiness, spinning sensation;
  • headache; or
  • back pain.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for Carafate Suspension (Sucralfate)

Carafate Suspension Professional Information

SIDE EFFECTS

Adverse reactions to sucralfate tablets in clinical trials were minor and only rarely led to discontinuation of the drug. In studies involving over 2700 patients treated with sucralfate, adverse effects were reported in 129 (4.7%).

Constipation was the most frequent complaint (2%). Other adverse effects reported in less than 0.5% of the patients are listed below by body system:

Gastrointestinal: diarrhea, dry mouth, flatulence, gastric discomfort, indigestion, nausea, vomiting Dermatological: pruritus, rash

Nervous System: dizziness, insomnia, sleepiness, vertigo

Other: back pain, headache

Post-marketing cases of hypersensitivity have been reported with the use of sucralfate suspension, including anaphylactic reactions, dyspnea, lip swelling, edema of the mouth, pharyngeal edema, pruritus, rash, swelling of the face and urticaria.

Cases of bronchospasm, laryngeal edema and respiratory tract edema have been reported with an unknown oral formulation of sucralfate.

Cases of hyperglycemia have been reported with sucralfate

Bezoars have been reported in patients treated with sucralfate. The majority of patients had underlying medical conditions that may predispose to bezoar formation (such as delayed gastric emptying) or were receiving concomitant enteral tube feedings.

Inadvertent injection of insoluble sucralfate and its insoluble excipients has led to fatal complications, including pulmonary and cerebral emboli. Sucralfate is not intended for intravenous administration.

Read the entire FDA prescribing information for Carafate Suspension (Sucralfate)

Related Resources for Carafate Suspension

Read the Carafate Suspension User Reviews »

© Carafate Suspension Patient Information is supplied by Cerner Multum, Inc. and Carafate Suspension Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors